Mkts

Outlook Therapeutics, Inc.

NASDAQ: OTLK
$0.41-0.03 (-6.14%)
As of Nov 13, 9:30 AM ET

Key statistics

Day range
0.410.46
52-week range
0.162.54
Today
Open0.46
Previous close0.41
Volume3.02M
Valuation
Market cap106.24M
P/E ratio—
EPS (TTM)-0.87
Income & risk
Dividend / yield—
Beta0.73
Avg volume2.41M
Discussion

OTLK News

Stories mentioning OTLK from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue1,505
Cost of Goods Sold149.0030.00440.00
Gross Profit(22.00)(1,237)(1,009)1,0660.000.000.000.00
Operating Expenses
Research & Development4,5013,6345,9797,1354,4079,66012,52311,202
Sales General & Admin9,5058,61210,3279,6797,98511,9478,361
Total Operating Expenses19,563
Operating Income (Loss)(14,027)(13,484)(17,314)(15,749)(12,392)(21,607)(22,877)(19,563)
Interest Income405.00
Interest Expense
Other Expense
Pretax Income(4,453)(20,153)(46,354)44,409
Tax Provision3.00
Net Income (Loss)(4,453)(23,058)(13,293)(20,153)(46,357)17,3785,69144,409
Earnings Per Share (Basic)(0.05)(0.38)(0.38)(0.55)(1.50)0.720.311.91
Earnings Per Share (Diluted)(0.05)(0.38)(0.38)(0.55)(1.50)0.720.31(0.89)
Weighted Average Shares Outstanding (Basic)81,83660,20534,79636,95730,87424,23418,54923,227
Weighted Average Shares Outstanding (Diluted)81,83660,20534,79636,95730,87424,23418,54925,476

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About OTLK

Outlook Therapeutics, Inc. (NASDAQ: OTLK) is a stock listed on the Nasdaq Stock Market under the ticker symbol OTLK. It last traded at $0.4100 (Nov 13, 2026, 9:30 AM ET), down 6.1% on the day. That gives Outlook Therapeutics a market capitalisation of $106.2M.

Over the past 52 weeks OTLK has traded between $0.1600 and $2.54.

For the quarter ended Mar 31, 2026 it reported a net loss of $4.5M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$4.5M—
Dec 31, 2025—-$23.1M—
Sep 30, 2025—-$13.3M—
Jun 30, 2025$1.5M-$20.2M-1339.1%

From Outlook Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…